Influenza virus vaccination of patients with SLE: Effects on generation of autoantibodies

Clinical Rheumatology

Volumn 21, Issue 5, 2002, Pages 369-372

  Abu Shakra, M ^a   Press, J ^a   Sukenik, S ^a   Buskila, D ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Autoantibodies; Influenza; SLE; Vaccination

Indexed keywords

ANTIMALARIAL AGENT; AUTOANTIBODY; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INFLUENZA VACCINE; METHOTREXATE; RIBONUCLEOPROTEIN ANTIBODY; STEROID;

ADULT; AGED; ANTIGEN ANTIBODY REACTION; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; DRUG EFFECT; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLUENZA VACCINATION; PRIORITY JOURNAL; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; VACCINATION;

EID: 0036741985     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670200099     Document Type: Article

References (19)

1. Cooper GS, Dooley MA, Treadwell EL, St. Clair EW, Parks CG, Gilkeson GS. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum 1998, 41:1714-24.
2. Strom BL, Reidenberg MM, West S, Snyder ES, Freundlich B, Stolley PD. Shingles, allergies, family medical history, oral contraceptive, and other potential risk factors for systemic lupus erythematosus. Am J Epidemiol 1994;140:632-42.
3. Gilkeson GS, Pippen AMM, Pisetsky DS. Induction of cross-reactive anti-DNA antibodies in pre-autoimmune NZB/NZW mice by immunization with bacterial DNA. J Clin Invest 1995;95:1398-402.
4. Abu-Shakra M, Zalmanson S, Neumann L, Flusser D, Sukenik S, Buskila D. Influenza virus vaccination of patients with SLE: Effects on disease activity. J Rheum 2000;27:1681-5.
5. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
6. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic 1upus erythematosus. Arthritis Rheum 1982;25:1271-7.
7. Stata Corp. 1997. Stata Statistical Software: Release 5.0. College Station, Texas: stata Corporation
8. Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun 1996;9:699-703.
9. Meyboom RHB, Fucik H, Edwards IR. Thrombocytopenia reported in association with hepatitis B and A vaccines. Lancet 1995;345:1638.
10. Tudela P Marti S. Bonal J. SLE and vaccination against hepatitis B. Nephron 1992;62:236-7.
11. Biron P, Montpetit P, Infante-Rivard C, Lery L. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch Int Med 1988;148:2685.
12. Hurwitz ES, Sconberger LB, Nelson DB, Holman RC. Guillain-Barré syndrome and the 1978-1979 influenza vaccine. N Engl J Med 1981;304:1557-61.
13. Uhari M, Rantala H, Niemela M. Cluster of childhood Guillain-Barré cases after an oral poliovaccine campaign. Lancet 1989;2:440-1.
14. Ayvazian LF, Badger TL. Disseminated lupus erythematosus occurring among student nurses. N Engl J Med 1948;239:565-70.
15. Abu-Shakra M, Urowitz MB, Gladman DD, Farewell V. Anti-Cardiolipin antibodies (ACL) in SLE: Clinical, and laboratory correlation. Am J Med 1995, 99:624-8.
16. Abu-Shakra M, Shoenfeld Y. Chronic infections and Autoimmunity. Immunol Ser 1991, 55:285-313.
17. Abu-Shakra M, Buskila D, Shoenfeld Y. Molecular mimicry between host and pathogens: Examples from parasites and implication. Immumol Lett 1999;67:147-52.
18. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison? J Autoimmun 2000;14:1-10.
19. Immunizations Practices Advisory Committee. General recommendations on immunization: guidelines from the Immunization Practices Advisory Committee, Centers for Disease Control. Ann fIntern Med 1989; 111: 133-42.